What is the relative effectiveness of enhanced influenza vaccines in older adults?
Summary
This research will determine which influenza vaccines are most effective. Predictors of (and disparities in) receiving adjuvanted, high-dose, and standard-dose influenza vaccines among Ontario adults aged 65+ years during 4 post-COVID-19-pandemic influenza seasons (2021-22 to 2024-25) will be identified. The effectiveness of adjuvanted, high-dose influenza will then be compared with standard-dose influenza vaccines.
Knowledge User
Office of the Chief Medical Officer of Health
Information
Project ID
2024-028/ 2025 0950 179 000
Contributing ICES Scientists
Type of Response
Status
AHRQ Project
2025
Evaluate urethral drug-coated balloon (optilume) for recurrent bulbar urethral strictures in adult men
Project ID: 2025-001/ 2026 0950 196 000
Project Year: 2025
Knowledge User: Ontario Health
ICES Scientist: Luke Mondor
Type of Response: Research report or technical brief
Status: Completed
AHRQ Project
2025
Seniors eligible for OSDCP 2025
Project ID: 2025-027/2026 0950 151 001
Project Year: 2025
Knowledge User: Halton Region-Public Health Surveillance & Evaluation
ICES Scientist: Luke Mondor
Type of Response: Research report or technical brief
Status: In progress